Global Bone Morphogenetic Protein (BMP) 2 Market Growth (Status and Outlook) 2024-2030

Global Bone Morphogenetic Protein (BMP) 2 Market Growth (Status and Outlook) 2024-2030

Bone morphogenetic proteins (BMPs) are naturally occurring proteins found in the human body. This family of proteins is involved in a myriad of cellular responses. Certain BMPs are osteoinductive—one of the three main categories of bone grafts—and play an active role in bone formation and maintenance.

Bone Morphogenetic Protein 2 (BMP-2) is a member of the bone morphogenetic protein family, a group of proteins that play a crucial role in bone and cartilage formation during embryonic development and adult tissue repair. BMP-2 is known for its potent osteoinductive properties, meaning it has the ability to stimulate the differentiation of mesenchymal stem cells into osteoblasts, the cells responsible for bone formation. This property makes BMP-2 a valuable therapeutic agent in orthopedic and dental surgeries, particularly in procedures aimed at promoting bone regeneration and spinal fusion.

The global Bone Morphogenetic Protein (BMP) 2 market size is projected to grow from US$ 682 million in 2024 to US$ 1160 million in 2030; it is expected to grow at a CAGR of 9.2% from 2024 to 2030.

LPI (LP Information)' newest research report, the “Bone Morphogenetic Protein (BMP) 2 Industry Forecast” looks at past sales and reviews total world Bone Morphogenetic Protein (BMP) 2 sales in 2022, providing a comprehensive analysis by region and market sector of projected Bone Morphogenetic Protein (BMP) 2 sales for 2023 through 2029. With Bone Morphogenetic Protein (BMP) 2 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bone Morphogenetic Protein (BMP) 2 industry.

This Insight Report provides a comprehensive analysis of the global Bone Morphogenetic Protein (BMP) 2 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Bone Morphogenetic Protein (BMP) 2 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bone Morphogenetic Protein (BMP) 2 market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bone Morphogenetic Protein (BMP) 2 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bone Morphogenetic Protein (BMP) 2.

Global core manufacturers of Bone Morphogenetic Protein (BMP) 2 include Medtronic, Jiuyuan Gene Engineering and Cellumed. North America is the largest consumption region, accounting for approximately 69% of the global market, followed by Asia-Pacific. In terms of product type, sponge is the largest market segment, with a share of more than 81%. In terms of application, the largest application is spinal fusion, with a share of approximately 68%.

This report presents a comprehensive overview, market shares, and growth opportunities of Bone Morphogenetic Protein (BMP) 2 market by product type, application, key players and key regions and countries.

Segmentation by Type:
Sponge
Gel

Segmentation by Application:
Spinal Fusion
Trauma Surgery
Oral Maxillofacial Surgery
reconstructive surgery

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Sponge
Gel

Segmentation by Application:
Spinal Fusion
Trauma Surgery
Oral Maxillofacial Surgery
reconstructive surgery

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Medtronic
Jiuyuan Gene Engineering
Cellumed

Please note: The report will take approximately 2 business days to prepare and deliver.